Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43146 (
tumour suppressor
)
5,935
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
promyelocytic leukemia
(
PML
)
tumour suppressor
is the organiser of
PML
nuclear bodies, which are domains the precise functions of which are still disputed. We show that upon several types of stress, endogenous
PML
proteins form nucleolar caps and eventually engulf nucleolar components. Only two specific
PML
splice variants (
PML
-I and
PML
-IV) are efficiently targeted to the nucleolus and the abundant
PML
-I isoform is required for the targeting of endogenous
PML
proteins to this organelle. We identified a nucleolar targeting domain within the evolutionarily conserved C-terminus of
PML
-I. This domain contains a predicted exonuclease III fold essential for the targeting of the
PML
-I C-terminus to nucleolar fibrillar centres. Furthermore, spontaneous or oncogene retrieval-induced senescence is associated with the formation of very large
PML
nuclear bodies that initially contain nucleolar components. Later, poly-ubiquitin conjugates are found on the outer shell or within most of these senescence-associated
PML
bodies. Thus, unexpectedly, the scarcely studied
PML
-I isoform links
PML
bodies, nucleolus, senescence and proteolysis.
...
PMID:A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells. 1787 36
Translocations of the retinoic acid receptor-alpha (RARalpha) locus with the
promyelocytic leukemia
zinc-finger (PLZF) or PML genes lead to expression of oncogenic PLZF-RARalpha or PML-RARalpha fusion proteins, respectively. These fusion oncoproteins constitutively repress RARalpha target genes, in large part through aberrant recruitment of multiprotein co-repressor complexes. PML and PML-RARalpha have previously been shown to associate with the retinoblastoma (Rb)
tumour suppressor
protein in its hypophosphorylated state. Here, we demonstrate that PLZF also interacts with Rb in vitro and in vivo. The interaction between PLZF and Rb is mediated through the Rb pocket and the region of PLZF that lies between its transcriptional repression (poxvirus and zinc-finger, POZ) and DNA-binding (zinc-finger) domains. In addition, Rb can simultaneously interact with PLZF and the E2F1 S phase-inducing transcription factor, suggesting that these proteins can exist in the same multiprotein complex. In contrast to the interaction of Rb with PML or E2F1, the PLZF-Rb interaction is not dependent on hypophosphorylation of Rb. These data are supported by chromatin immunoprecipitation analysis, which indicates that PLZF associates with the promoter region of CDC6, a known E2F/Rb target gene. Co-expression of PLZF and Rb results in enhancement of transcriptional repression of PLZF and E2F/Rb target genes, indicating functional co-operation between the two proteins. Both PLZF and Rb have been shown to function in stem cells and taken together these data suggest that interactions between PLZF and Rb could be important in stem cell biology.
...
PMID:Retinoblastoma protein and the leukemia-associated PLZF transcription factor interact to repress target gene promoters. 1850 36
The nuclear lamina provides structural support to the nucleus and has a central role in nuclear organization and gene regulation. Defects in its constituents, the lamins, lead to a class of genetic diseases collectively referred to as laminopathies. Using live cell imaging, we observed the occurrence of intermittent, non-lethal ruptures of the nuclear envelope in dermal fibroblast cultures of patients with different mutations of lamin A/C. These ruptures, which were absent in normal fibroblasts, could be mimicked by selective knockdown as well as knockout of LMNA and were accompanied by the loss of cellular compartmentalization. This was demonstrated by the influx of cytoplasmic transcription factor RelA and regulatory protein Cyclin B1 into the nucleus, and efflux of nuclear transcription factor OCT1 and nuclear structures containing the
promyelocytic leukemia
(
PML
)
tumour suppressor
protein to the cytoplasm. While recovery of enhanced yellow fluorescent protein-tagged nuclear localization signal in the nucleus demonstrated restoration of nuclear membrane integrity, part of the mobile
PML
structures became permanently translocated to the cytoplasm. These satellite
PML
structures were devoid of the typical
PML
body components, such as DAXX, SP100 or SUMO1. Our data suggest that nuclear rupture and loss of compartmentalization may add to cellular dysfunction and disease development in various laminopathies.
...
PMID:Repetitive disruptions of the nuclear envelope invoke temporary loss of cellular compartmentalization in laminopathies. 2183 85